Analyst Research Report Snapshot

Title:

GW PHARMACEUTICALS - CRITICAL YEAR AHEAD

Price:

$10.00

Provider:

Edison Investment Research

Date:

24 Jan 2008

Pages:

5

Type:

AcrobatPDF

Companies referenced:

GWP.L

Available for Immediate Download
Summary:

2008 will be critical for GW, with results from three late-stage clinical studies of Sativex due this year. Results from its trial in neuropathic pain associated with multiple sclerosis (MS) are due in the next few weeks, while those in spasticity associated with MS and cancer pain are expected at the end of the year. FOR MORE INFORMATION ON ATTACHED RESEARCH PLEASE CALL 020 7190 1755 OR EMAIL RESEARCH@EDISONINVESTMENTRESEARCH.CO.UK OR VISIT WWW.EDISONINVESTMENTRESEARCH.CO.UK

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.